Glucose Health annual shareholders’ equity
2010
2011
2012
2013
2014
2015
2016
Glucose Health Shareholders’ Equity Growth & History (GLUC)
Glucose Health's shareholders’ equity was −$495,447 for fiscal 2016.
View full Glucose Health company overviewGlucose Health annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2016 | 2016-12-31 | −$495,447 | −$107,628 | — |
| 2015 | 2015-12-31 | −$387,819 | −$107,267 | — |
| 2014 | 2014-12-31 | −$280,552 | −$82,794 | — |
| 2013 | 2013-12-31 | −$197,758 | −$219,958 | — |
| 2012 | 2012-12-31 | $22,200 | $208,222 | — |
| 2011 | 2011-12-31 | −$186,022 | $408,551 | — |
| 2010 | 2010-12-31 | −$594,573 | — | — |
Glucose Health quarterly shareholders’ equity
Q4.10
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q3 2017 | 2017-09-30 | −$426,232 | −$52,600 | — |
| Q2 2017 | 2017-06-30 | −$449,289 | −$232,594 | — |
| Q1 2017 | 2017-03-31 | −$523,566 | −$120,435 | — |
| Q4 2016 | 2016-12-31 | −$495,447 | −$107,628 | — |
| Q3 2016 | 2016-09-30 | −$373,632 | −$11,875 | — |
| Q2 2016 | 2016-06-30 | −$216,695 | $113,647 | — |
| Q1 2016 | 2016-03-31 | −$403,131 | −$70,873 | — |
| Q4 2015 | 2015-12-31 | −$387,819 | −$107,267 | — |
| Q3 2015 | 2015-09-30 | −$361,757 | −$112,323 | — |
| Q2 2015 | 2015-06-30 | −$330,342 | −$107,832 | — |
| Q1 2015 | 2015-03-31 | −$332,258 | −$135,467 | — |
| Q4 2014 | 2014-12-31 | −$280,552 | −$82,794 | — |
| Q3 2014 | 2014-09-30 | −$249,434 | −$471,717 | — |
| Q2 2014 | 2014-06-30 | −$222,510 | −$479,827 | — |
| Q1 2014 | 2014-03-31 | −$196,791 | −$88,437 | — |
| Q4 2013 | 2013-12-31 | −$197,758 | −$219,958 | — |
| Q3 2013 | 2013-09-30 | $222,283 | $446,295 | — |
| Q2 2013 | 2013-06-30 | $257,317 | $202,987 | +373.62% |
| Q1 2013 | 2013-03-31 | −$108,354 | $50,396 | — |
| Q4 2012 | 2012-12-31 | $22,200 | $208,222 | — |
| Q3 2012 | 2012-09-30 | −$224,012 | $54,543 | — |
| Q2 2012 | 2012-06-30 | $54,330 | — | — |
| Q1 2012 | 2012-03-31 | −$158,750 | — | — |
| Q4 2011 | 2011-12-31 | −$186,022 | $408,551 | — |
| Q3 2011 | 2011-09-30 | −$278,555 | — | — |
| Q4 2010 | 2010-12-31 | −$594,573 | — | — |
Glucose Health shareholders’ equity trends
Over the last five fiscal years, Glucose Health's shareholders’ equity decreased from −$186,022 to −$495,447, a change of −$309,425. The latest reported quarter, Q3 2017, shows −$426,232.
About the metric
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
Calculation and source
SEC-reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company SEC filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Glucose Health source filings ↗